FTC Makes DaVita Sell Dialysis Clinics In $689M DSI Deal

Law360, New York (September 2, 2011, 6:53 PM EDT) -- The Federal Trade Commission said Friday that it will require DaVita Inc. to sell 29 outpatient dialysis clinics to resolve the agency's claims that its proposed $689 million acquisition of rival DSI Renal Inc. would be anti-competitive.

The agency filed a complaint outlining its allegations that the deal would have anti-competitive effects and a consent judgment requiring the sale of the 29 clinics to Dialysis Newco Inc., a corporation formed by venture capital firms Frazier Healthcare and New Enterprise Associates.

Denver-based DaVita entered into the deal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.